VAERS ID: 2331009

AGE: 56| SEX: M|STATE: FR

Description

Muscle cramps, spastic signs of paralysis on the hands after the first vaccination, and then again the same after the second vaccination; Inappropriate schedule of vaccine administered; Muscle cramps, spastic signs of paralysis on the hands after the first vaccination, and then again the same after the second vaccination; Muscle cramps, spastic signs of paralysis on the hands after the first vaccination, and then again the same after the second vaccination; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from the Regulatory Authority-WEB. Regulatory number: DE-PEI-CADR2022272204 (RA). Other Case identifier(s): DE-CADRPEI-2022272204 (RA Webportal), DE-PEI-202200071965 (RA). A 57-year-old male patient received BNT162b2 (COMIRNATY), on 16Jun2021 as dose 2, 0.3 ml single (Lot number: FD9234) at the age of 56 years for covid-19 immunisation. The patient's relevant medical history included: "pollen allergy" (unspecified if ongoing); "Drug Allergy" (unspecified if ongoing), notes: Novalgin; "Heart attack", start date: 2019 (unspecified if ongoing), notes: Heart attack 2019; "Crohn's disease" (unspecified if ongoing); "Bechterew's disease" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: comirnaty (Dose 1, Strength: 0.3 mL, Batch/lot number: EX8679), administration date: 05May2021, for Covid-19 immunization, reaction(s): "Paralysis", "Myalgia", "Muscle cramps". The following information was reported: PARALYSIS (medically significant), MYALGIA (non-serious), MUSCLE SPASMS (non-serious), outcome "recovered" (16Jul2021) and all described as "Muscle cramps, spastic signs of paralysis on the hands after the first vaccination, and then again the same after the second vaccination"; INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (non-serious), outcome "unknown", described as "Inappropriate schedule of vaccine administered". Result of Assessment for event Paralysis and Muscle cramps are: D. Unclassifiable, Result of Assessment for event Myalgia are: B. Indeterminate. No follow-up attempts are possible. No further information is expected.; Sender's Comments: Linked Report(s) : DE-PFIZER INC-202200871453 Same patient/drug, different dose/events.;

Symptoms

Inappropriate schedule of product administration, Muscle spasms, Myalgia, Paralysis

Vaccines

VAX DATE: 06-16-2021| ONSET DATE: | DAYS TO ONSET:
NameDose #TypeManufacturerLotRouteSite
COVID19 (COVID19 (PFIZER-BIONTECH)) 2 COVID19 PFIZER\BIONTECH FD9234 Unknown Unknown

RECVDATE:06-24-2022
RPT_DATE:
CAGE_YR:
CAGE_MO:
DIED:U
DATEDIED:
L_THREAT:U
ER_VISIT:U
HOSPITAL:U
HOSPDAYS:
X_STAY:U
DISABLE:U
RECOVD:Y
LAB_DATA:
V_ADMINBY:OTH
OTHER_MEDS:
CUR_ILL:
HISTORY:Medical History/Concurrent Conditions: Bechterew's disease; Crohn's disease; Drug allergy (Novalgin); Heart attack (Heart attack 2019); Pollen allergy
PRIOR_VAX:
SPLTTYPE:DEPFIZER INC202200846482
FORM_VERS:2
TODAYS_DATE:06-23-2022
BIRTH_DEFECT:U
OFC_VISIT:U
ER_ED_VISIT:U
ALLERGIES:
V_FUNDBY:

Questions? Comments? Bugs?
[email protected]
Due to the high volume of inquiries, please be patient with response times.

AND PLEASE read the FAQ first.

OpenVAERS is a private organization that posts publicly available CDC/FDA data of injuries reported post-vaccination. Reports are not proof of causality.